GL1X · GenesisL1 explorer

MolNFT v1 · #56198 · protein

Unphosphorylated mitogen activated protein kinase ERK2 in complex with (4-{[5-carbamoyl-4-(3-METHYLANILINO)PYRIMIDIN 2-YL]AMINO}PHENYL)ACETIC acid

2Z7L · Mitogen-activated protein kinase 1: “Unphosphorylated mitogen activated protein kinase ERK2 in complex with…”. X-ray diffraction, 2 ligands (S91, SO4), 4 pockets (best druggability 0.61). MolNFT v1 #56198 on GenesisL1: 3D structure…

PDB
2Z7L
Type
protein
Length
329 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
S91, SO4
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein32941% helix, 13% strandP63086

Ligands and binding sites

  • S91 · [4-({5-(aminocarbonyl)-4-[(3-methylphenyl)amino]pyrimidin-2-yl}amino)phenyl]acetic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • BME · Beta-mercaptoethanol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13550.610.7733S91, BME
2940.510.8319empty
3690.300.7421empty
4580.290.7414empty

Modifications

Observed in the structure: 3 covalent (additive adduct).

Compared structures

  • 2Z7L · Unphosphorylated Mitogen Activated Protein Kinase ERK2 in Complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.